Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01462188

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Marco Valgimigli (from the registry)
Registry
  • NCT NCT01462188
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01462188. Randomized; single masking; primary purpose treatment. Start 2011-10 (registry gives no type); primary completion 2012-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Optimizing Infarct Size by Transforming Emergent Stenting Into an Elective Procedure Study
Acronym
OPTIMASTRATEGY
Intervention (Procedure)
Immediate stenting
Intervention (Procedure)
Delayed stenting
Lead sponsor
Marco Valgimigli (class: other)

Record details

Record id
cardio:ct-nct01462188
Content hash
76954015a2efe565521fb805b162c0878335c214822162209f2dece9ce61dc33